Cited by 752Immune Cell Function and InteractionImmune cells in cancerReproductive System and Pregnancy

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

Open access
Lopez-Vergès, Sandra, Milush, Jeffrey M., Pandey, Suchitra, York, Vanessa A., Arakawa-Hoyt, Janice, Pircher, Hanspeter, Norris, Philip J., Nixon, Douglas F. +1 more·2010·Blood

Abstract

Natural killer (NK) cells are innate immune lymphocytes that express a heterogeneous repertoire of germline-encoded receptors and undergo a distinct pattern of maturation. CD57 is a marker of terminal differentiation on human CD8+ T cells. Very few newborn or fetal NK cells express CD57; however, the frequency of CD57-bearing NK cells increases with age. We assessed the transcriptional, phenotypic, and functional differences between CD57+ and CD57− NK cells within the CD56dim mature NK subset. CD57+ NK cells express a repertoire of NK-cell receptors, suggestive of a more mature phenotype, and proliferate less when stimulated with target cells and/or cytokines. By contrast, a higher frequency of CD57+ NK cells produced interferon-γ and demonstrated more potent lytic activity when these cells were stimulated through the activating receptor CD16; however, they are less responsive to stimulation by interleukin-12 and interleukin-18. Finally, CD57 expression is induced on CD57−CD56dim NK cells after activation by interleukin-2. A combination of a mature phenotype, a higher cytotoxic capacity, a higher sensitivity to stimulation via CD16, with a decreased responsiveness to cytokines, and a decreased capacity to proliferate suggest that CD57+ NK cells are highly mature and might be terminally differentiated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2010-04-282301

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CD57+CD3- NK cells are terminally differentiated, have higher cytolytic capabilities, act as innate immune regulators, are less responsive to cytokines, and are connected to autoimmunity and immunodeficiency.

    “These NK cells are functionally different than traditional, CD56 + NK cells-they are terminally differentiated and have higher cytolytic capabilities, and generally act as innate immune regulators despite being less responsive to cytokines and connected to autoimmunity and immunodeficiency (Lopez-Verges et al, 2010;Nielsen et al, 2013).”

    From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Lopez-Verges et al, 2010

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lopez-Vergès, S., Milush, J. M., Pandey, S., York, V. A., Arakawa-Hoyt, J., Pircher, H., Norris, P. J., Nixon, D. F., & Lanier, L. L.
Affiliations
  • Department of Microbiology and Immunology and the Cancer Research Institute, University of California–San Francisco, San Francisco, CA;
  • University of California, San Francisco (US)
  • Blood Systems Research Institute (US)
  • University of Freiburg (DE)
Venue
Blood
Published
2010-11-11
Volume
116
Issue
19
Pages
3865-3874
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2087590625
Cited by
752
References
50
Citations by year
2026: 34 · 2025: 40 · 2024: 58 · 2023: 35 · 2022: 55 · 2021: 54 · 2020: 61 · 2019: 55 · 2018: 43 · 2017: 55 · 2016: 54 · 2015: 52 · 2014: 44 · 2013: 50 · 2012: 25
FWCI
15.23
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl095470-04)
  • National Heart, Lung, and Blood Institute (HL095470, R01 HL-095470, T32HL007185)
  • National Institute of Allergy and Infectious Diseases (AI-068129, R01AI068129, P01AI064520, R01AI083113, AI 64520)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
CD57, natural killer cells, NK cell maturation, NK cell receptors, CD16, interferon-gamma, cytotoxicity, IL-12, IL-18, interleukin-2, NK cell proliferation, terminal differentiation, NK cell subsets
MeSH terms
Adult, Cell Differentiation, Cytotoxicity, Immunologic, Humans, Interferon-gamma, Killer Cells, Natural, Lymphocyte Activation, Cell Death, Receptors, IgG, Interleukin-12, CD57 Antigens, CD56 Antigen, Interleukin-18, Gene Expression Profiling, Cell Proliferation, GPI-Linked Proteins, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review